The Food and Drug Administration (FDA) inspected Cincinnati Eye Bank for Sight Restoration, LLC in Cincinnati on April 16, examining the facility’s practices involving human cellular, tissue, and gene therapies, according to data posted on the FDA’s website.
The final findings reported that Cincinnati Eye Bank for Sight Restoration, LLC did not require any changes to its operational management.
The FDA regularly inspects facilities nationwide to confirm that workplaces and products meet FDA-regulated laws and regulations intended to protect public health. These inspection results are released publicly.
According to its website, the FDA is a federal agency charged with overseeing the safety and quality of human and animal drugs, biological products, medical devices and tobacco items.
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.
